Hepatitis C virus antibodies. Seroprevalence in HIV infected patients
Quaranta, J.F.; Delaney, S.R.; Alleman, S.; Cassuto, J.P.; Allain, J.P.; Dellamonica, P.
Presse Medicale 21(29): 1389
1992
ISSN/ISBN: 0755-4982 PMID: 1454774 Document Number: 388390
Document emailed within 1 workday
Related Documents
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312Suto, C.; Murakami, H.; Kobayashi, Y.; Nagamine, T.; Saitoh, T.; Kasamatsu, T.; Ogawara, H.; Murakami, M. 2015: High Frequency of Hepatitis B Core and Surface Antibodies in Hepatitis C Virus-Infected Patients on the Screening Examination Rinsho Byori. Japanese Journal of Clinical Pathology 63(3): 305-311
Aggarwal, R.; Naik, S.; Yachha, S.K.; Naik, S.R. 1999: Seroprevalence of antibodies to hepatitis a virus among children in Northern India Indian Pediatrics 36(12): 1248-1250
Bañares, R.; Bory, F.; Costa, J.; Dal-Ré, R.; González, A.; Navasa, M.; Planas, R.; Sansó, A.; Vargas, V. 1996: Seroprevalence of hepatitis a antibodies in patients with chronic hepatitis Gastroenterologia y Hepatologia 19(3): 183
Celen, M.K.; Ayaz, C.; Hosoglu, S.; Geyik, M.F.; Ulug, M. 2006: Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey Saudi Medical Journal 27(5): 617-620
Liang, S.H.; Lo, Y.-C.; Lin, H.-H.; Chang, S.-Y.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Hung, C.-C.; Chang, S.-C. 2008: Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital Journal of Microbiology Immunology and Infection 41(3): 200-208
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Sarr, A.; Sow, A.M.; Diallo, A.; Mendez, V.; Ka Cisse, M. 1996: Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma Dakar Medical Spec No: 21-23
Jensen, D.M.; Peterson, D.A.; Wolfe, L.G.; Hurley, T.; Payne, J.A.; Ogden, J. 1984: Antibodies directed against human liver specific membrane lipoprotein (LSP) in marmosets experimentally infected with the hepatitis a virus Clinical and Experimental Immunology 55(3): 535-540
Dumortier, J.ér.ôm.; Chiarello, P.; Adham, M.; Delafosse, B.; Chayvialle, J.-A.; Scoazec, J.-Y.; Boillot, O. 2002: Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus Gastroenterologie Clinique et Biologique 26(11): 1061-1062
Radkowski, M.; Wang, L.F.; Vargas, H.; Wilkinson, J.; Rakela, J.; Laskus, T. 2001: Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors Transplantation 72(5): 833-838
Lecot, C.; Jeantils, V.; Ovaguimian, L.; Krivitzky, A.; Bréchot, C.; Dény, P. 1993: Polymerase chain reaction-based detection of hepatitis D virus RNA in patients infected with human immunodeficiency virus Progress in Clinical and Biological Research 382: 329-335
Parande, M.V.; Mantur, B.G.; Parande, A.M.; Shinde, R.S.; Roy, S.; Jnaneshwar, K.B.; Chandrashekhar, M.R. 2013: Seroprevalence of human immunodeficiency virus and hepatitis B virus co-infection in Belgaum, southern India Indian Journal of Medical Research 138(3): 364-365
Sánchez Casado, M.L.; Calderón Morales, M.T.; Muñoz Sanz, A.; Iradier Barrios, C. 1988: Seroprevalence of hepatitis B virus and human immunodeficiency virus infections in the personnel of a general hospital Medicina Clinica 91(16): 637
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112
Stark, K.; Meyer, C.G.; Tacke, M.; Schwarz, A.; Braun, C.; Huzly, D.; Engel, A.M.; May, J.; Bienzle, U. 1997: Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors Transplantation 64(4): 608-612
Nie, Q.; Wang, P.; Zhou, Y. 2002: Quantitation of hepatitis C virus RNA in amniotic fluid of gravida infected by hepatitis C virus Zhonghua Fu Chan Ke Za Zhi 37(1): 19-21